Metagenomi Therapeutics, Inc.
MGX • NASDAQ • Stock Fundamentals
Metagenomi Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jian Irish, with a market cap of $47.1M.
Market Cap$47.1M
Employees236.0
CEOJian Irish
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Metagenomi Therapeutics, Inc. FAQ
Common questions about Metagenomi Therapeutics, Inc.
Metagenomi Therapeutics, Inc. (MGX) has a market capitalization of $47.1M and trades on NASDAQ.
Metagenomi Therapeutics, Inc. has approximately 236 employees.